The target compound was synthesized in analogy to described procedures [1] [2] [3] [4] [5] [6] . 2-Thiouracil was silylated with hexamethyldisilazane (HMDS) in the presence of a catalytic amount of trimethylsilyl chloride. After excess HMDS was distilled off, the raw product was reacted with l-O-acetyl-2,3,5-tri-0-benzoyl-/?-D-ribofuranose in dichloroethane in the presence of tm(TV)chloride [ 1 ] . Hydrolysis with saturated aqueous sodium hydrogen carbonate solution yielded 2-thio-1 -(2 ',3 ',5 '-tri-0-benzoyl-/3-Dribofuranosyl)-3//-pyrimidine-2,4-dione [1], which was subsequently alkylated with 1-iodopropane in dichloromethane in the presence of triethylamine as described for the homologous ethyl derivative [5] . The benzoyl groups were removed by reaction with a saturated solution of ammonia in methanol [6] yielding the title compound l-((2Ä,3Ä,4S,5Ä)-3,4-dihydroxy-5-hydroxymethyltetrahydrofuran-2-y l)-2-propy lsulfanyl-1 W-pyrimidin-4-one, which was purified by column chromatography (dichloromethane/methanol, 5:1). Crystals were obtained by dissolution of 50 mg of the pure compound in 3 ml of acetone followed by the addition of 7 ml of n-hexane and slow evaporation of the solvent over a period of several months at room temperature.
Source of material
The target compound was synthesized in analogy to described procedures [1] [2] [3] [4] [5] [6] . 2-Thiouracil was silylated with hexamethyldisilazane (HMDS) in the presence of a catalytic amount of trimethylsilyl chloride. After excess HMDS was distilled off, the raw product was reacted with l-O-acetyl-2,3,5-tri-0-benzoyl-/?-D-ribofuranose in dichloroethane in the presence of tm(TV)chloride [ 1 ] . Hydrolysis with saturated aqueous sodium hydrogen carbonate solution yielded 2-thio-1 -(2 ',3 ',5 '-tri-0-benzoyl-/3-Dribofuranosyl)-3//-pyrimidine-2,4-dione [1] , which was subsequently alkylated with 1-iodopropane in dichloromethane in the presence of triethylamine as described for the homologous ethyl derivative [5] . The benzoyl groups were removed by reaction with a saturated solution of ammonia in methanol [6] yielding the title compound l-((2Ä,3Ä,4S,5Ä)-3,4-dihydroxy-5-hydroxymethyltetrahydrofuran-2-y l)-2-propy lsulfanyl-1 W-pyrimidin-4-one, which was purified by column chromatography (dichloromethane/methanol, 5:1). Crystals were obtained by dissolution of 50 mg of the pure compound in 3 ml of acetone followed by the addition of 7 ml of n-hexane and slow evaporation of the solvent over a period of several months at room temperature.
Experimental details
Owing to sufficient resonant scattering from the sulfur and oxygen atoms, the data allowed for the determination of the absolute structure of the title compound (x(Flack) = 0.01 (6) , Rl = 0.039).
A cross check refinement of the enantiomer yielded (x(Flack) = 0.98(6), Ä1 = 0.040). The majority of the Η atoms could be determined from difference Fourier calculations. The hydrogens bonded to C18 and C19 were treated as 'riding' due to the thermal displacements of their carrier atoms.
Discussion
The crystal structure contains 4 symmetry equivalent molecules per unit cell. All intramolecular bond lengths are normal. The main part of the molecule consists of an almost planar aromatic system (C2, N6, C7, N8, C9, C10, CI 1, S16,020) with an r.m.s. deviation from the least squares plane of0.034 À. A second plane, which is defined by S16, C17, C18, C19 with r.m.s. = 0.0009 Â, is tilted by 87. 
